“ANTITUMOR EFFECT OF SUNITINIB AND BORTEZOMIB ON BREAST CANCER CELL LINE IN VITRO”, Вопр. онкол., vol. 63, no. 1, pp. 141–145, Jan. 2017, doi: 10.37469/0507-3758-2017-63-1-141-145.